Skip to main content
. Author manuscript; available in PMC: 2019 Aug 22.
Published in final edited form as: J Orthop Res. 2018 Feb 22:10.1002/jor.23882. doi: 10.1002/jor.23882

Figure 6. Mitoprotective efficacy depends on treatment time.

Figure 6

A) Chondrocyte death (% dead cells) in injured explants (n=6/ group), treated with SS-31 at 0, 1, or 6 hours was equivalent to uninjured controls. B) Cartilage matrix degeneration, measured by glycosaminoglycan (GAG) loss into the media was equivalent to uninjured controls in all treatment groups. Groups that do not share a letter are significantly different at p ≤ 0.05. Error bars = ±s.d.